Literature DB >> 11386608

Renal elimination of protein S-100beta in pigs with acute encephalopathy.

L M Ytrebø1, G I Nedredal, C Korvald, O J Holm Nielsen, T Ingebrigtsen, B Romner, J Aarbakke, A Revhaug.   

Abstract

BACKGROUND: Protein S-100beta is an established biochemical marker for cerebral injury in serum. For the further interpretation and possible use of S-100beta serum measurements in acute hepatic encephalopathy, renal elimination of S-100beta was measured in pigs with elevated S-100beta levels due to hepatic encephalopathy.
METHODS: Eighteen female Norwegian Landrace pigs were randomly allocated to either hepatic devascularization (n=13) or sham operation (n=5). Repeated samples from the common carotid artery, right renal vein, and urine were simultaneously drawn for S-100beta analysis, using the Sangtec100 Liamat immunoassay.
RESULTS: In hepatic devascularized pigs, arterial serum levels of S-100beta increased from 0.96+/-0.04 microg/L (mean +/- SEM) at t = 0h to 1.74+/-0.11 microg/L (mean +/- SEM) at t = 5 h. Urinary excretion increased simultaneously from 8.48+/-3.66 ng/h (mean +/- SEM) to 20.4+/-9.54 ng/h (mean +/- SEM), while renal arterial-venous fluxes for both kidneys increased from 1022+/-404 ng/h (mean +/- SEM) to 2444+/-590 ng/h (mean +/- SEM).
CONCLUSIONS: Increased arterial S-100beta levels in pigs with acute hepatic encephalopathy are not a result of decreased renal elimination. The large difference between the renal arterial venous S-100beta concentrations and the urinary excretion of S-100beta indicate that renal metabolism is the major route of elimination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386608     DOI: 10.1080/003655101300133658

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

1.  Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.

Authors:  Linda Papa; Linnet Akinyi; Ming Cheng Liu; Jose A Pineda; Joseph J Tepas; Monika W Oli; Wenrong Zheng; Gillian Robinson; Steven A Robicsek; Andrea Gabrielli; Shelley C Heaton; H Julia Hannay; Jason A Demery; Gretchen M Brophy; Joe Layon; Claudia S Robertson; Ronald L Hayes; Kevin K W Wang
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

2.  Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs.

Authors:  Sambit Sen; Lars M Ytrebø; Christopher Rose; Ole-Martin Fuskevaag; Nathan A Davies; Geir I Nedredal; Roger Williams; Arthur Revhaug; Rajiv Jalan
Journal:  Intensive Care Med       Date:  2004-01-21       Impact factor: 17.440

3.  Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.

Authors:  Linda Papa; Claudia S Robertson; Kevin K W Wang; Gretchen M Brophy; H Julia Hannay; Shelley Heaton; Ilona Schmalfuss; Andrea Gabrielli; Ronald L Hayes; Steven A Robicsek
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

4.  [Identification of high-risk patients after minor craniocerebral trauma. Measurement of nerve tissue protein S 100].

Authors:  P Biberthaler; T Mussack; K-G Kanz; U Linsenmaier; K-J Pfeifer; W Mutschler; M Jochum
Journal:  Unfallchirurg       Date:  2004-03       Impact factor: 1.000

5.  Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.

Authors:  Eyal Itshayek; Jeremy D Kark; Haim Ovadia; Carolyn F Weiniger; Yigal Shoshan; Sharon Einav
Journal:  BMC Clin Pathol       Date:  2008-09-19

6.  Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational study.

Authors:  Sharon Einav; Yigal Shoshan; Haim Ovadia; Idit Matot; Moshe Hersch; Eyal Itshayek
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein in Patients with Mild Traumatic Brain Injury.

Authors:  Ali Meshkini; Amir Ghorbani Haghjo; Zahra Hasanpour Segherlou; Masoud Nouri-Vaskeh
Journal:  Bull Emerg Trauma       Date:  2021-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.